Infliximab for induction and maintenance therapy for ulcerative colitis.
Moss
Alan C
AC
Farrell
Richard J
RJ
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D016032:Randomized Controlled Trials as Topic
D000911:Antibodies, Monoclonal; D000069285:Infliximab